/ Sun Pharm Gains After Setting Antitrust Litigation In US ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Monday, 10 July 2017

On Monday early morning trade session Sun Pharmaceutical Industries gained over 2%, has settled antitrust litigation in the US.

On Monday BSE the company is trading at Rs 560.45 up by Rs 10.75 or 1.96% and hit the Intraday high of Rs 567.30.

Sun Pharma is one of their wholly owned subsidiary companies which have entered into the settlements in the United States District court for the Eastern District with certain plaintiffs in the Modafini Antitrust Litigation matter and are currently pending. The settlement remainsare confidential and extend to all claims brought by Apotex Corporation and the Retailer Purchaser Plaintiffs.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717